Institute and Individual Awards
The below list highlights just some of the awards recently earned by Dana-Farber and its staff.
The Institute
Dana-Farber has been given the highest ranking of any New England cancer hospital and the fifth-highest rating in the nation by U.S.News & World Report. The rankings, part of the magazine's annual "America's Best Hospitals" guide, were published in the July 14, 2008, issue.
Dana-Farber earned the prestigious Magnet status from the American Nurses Credentialing Center (ANCC), the highest institutional honor awarded for nursing excellence. Dana-Farber is the only cancer center in New England - and one of fewer than 150 hospitals worldwide - to earn the distinction. The announcement was made in June 2005.
Individuals
David Pellman, MD, of Pediatric Oncology, was one of 56 scientists selected in early 2008 as an investigator of the Howard Hughes Medical Institute (HHMI), a non-profit medical research organization that ranks as one of the nation's largest philanthropies.
Todd Golub, MD, of Pediatric Oncology, was awarded a 2008 E. Mead Johnson Award by the Society for Pediatric Research for his pioneering work in cancer genomics.
Monica M. Bertagnolli, MD, and Bruce E. Johnson, MD, were elected to the Board of Directors of the American Society of Clinical Oncology (ASCO). ASCO's board is made up of oncology leaders who are elected to represent one of five distinct areas within the oncology field. They will begin three-year terms on June 3, 2008.
Anthony del Campo, vice president for the Office of Research and Technology Ventures, has been elected the 2008 Massachusetts Area Technology Transfer Offices (MATTO) executive committee chairman. MATTO is a nonprofit association of technology transfer organizations.
Kenneth Anderson, MD, director of the Jerome Lipper Multiple Myeloma Center, received honors from the American Society of Hematology (ASH) and ROFEH International for his work in myeloma research, care, and public awareness at the ASH annual meeting in Atlanta in December 2007.
George P. Canellos, MD, the William Rosenberg Professor of Medicine at Harvard Medical School and founding chief of Medical Oncology at Dana-Farber, was awarded the 2007 Karl Musshoff Prize for lifetime achievements in the field of Hodgkin lymphoma.
Edward J. Benz Jr., MD, Dana-Farber's president and chief executive officer, has been appointed president of the Association of American Cancer Institutes (AACI). As AACI president, Dr. Benz will help shape the organization's policy on issues important to the nation's cancer research institutions.
Margaret A. Shipp, MD, of Medical Oncology received the 2007 Northwestern Medical Women Faculty Organization's Annual Distinguished Woman in Medicine and Science Award Northwestern University School of Medicine.
Kenneth C. Anderson, MD, director of the Jerome Lipper Multiple Myeloma Center, has been named editor-in-chief of Clinical Cancer Research, an oncology journal published by the American Association for Cancer Research.
Nancy Berliner, MD, co-chief of Hematology at Dana-Farber/Brigham and Women's Cancer Center (DF/BWCC), was elected vice president of American Society for Hematology and will become president in two years.
Patti Branowicki, MS, RN, CNAA, director of Nursing Patient Care Services for Pediatric Oncology at DFCI and vice president of Medicine Patient Services at Children's Hospital Boston, was recently named a “Champion in Healthcare” by the Boston Business Journal in its nursing category.
Jane C. Weeks, MD, MSc, of Medical Oncology, has received the 2007 M. D. Anderson Cancer Center's Heath Memorial Award. The Heath Memorial Award honors those who have made outstanding contributions to cancer patient care through the clinical application of basic cancer knowledge.
Jennifer R. Brown, MD, Ph.D., of Hematology Oncology, received the 2006 Young Scientist Award from the Lymphoma Foundation of America. The Lymphoma Foundation of America is a national organization devoted solely to helping lymphoma patients and their families.
Edward J. Benz Jr., MD, Dana-Farber's president and chief executive officer, received the American Society of Hematology's Mentoring Award in Basic Science.
Levi Garraway, MD, PhD, a principal investigator in the Center for Cancer Genome Discovery at Dana-Farber, has been selected for a 2007 NIH Director's New Innovator Award. Chosen from more than 2,200 applicants, Garraway and 28 other scientists from across the United States each will receive $1.5 million of research support over five years.
Gary Gilliland, MD, PhD, whose research has dramatically improved the understanding and potential treatment of bone-marrow cancers, received the 2007 Stanley Korsmeyer Award from the American Society for Clinical Investigation.
Kenneth C. Anderson, MD, chief of the Division of Hematologic Neoplasia, was recognized with the Joseph H. Burchenal Clinical Research Award for his decades of bench-to-bedside research developing novel therapies for myeloma, a progressive blood disease.
Edward J. Benz Jr., MD, Dana-Farber's president and chief executive officer, was named the 2007 Philip K. Bondy Visiting Professor at Yale University School of Medicine, the Tinsley Harrison Visiting Professor at Vanderbilt University and the Hickman Lecturer Central Society for Clinical Research.
Todd Golub, MD, of Dana-Farber and the Broad Institute of Harvard and MIT is one of three young researchers to receive the 2007 Paul Marks Prize for Cancer Research from Memorial Sloan-Kettering Cancer Center (MSKCC). The biennial prize recognizes significant contributions to the basic understanding and treatment of cancer by scientists under the age of 45 at the time they are nominated.
Jay R. Harris, MD, Chair of the Dept. of Radiation Oncology has been awarded the 2007 Gold Medal from The American Society of Therapeutic Radiology and Oncology (ASTRO) The Gold Medal is ASTRO's highest honor and is bestowed on revered members who have made outstanding contributions to the field of radiation oncology, including research, clinical care, teaching and service.
Kornelia Polyak, MD, PhD, of Medical Oncology received the American Academy of Cancer Research Award for Outstanding Achievement in Cancer Research – given annually to an investigator age 40 or under – for her work in understanding the molecular basis of human cancer.
Arthur Skarin, MD, of Medical Oncology, is the new president of the Massachusetts Society of Clinical Oncology. The organization promotes standards of cancer care and broad access to high quality cancer treatment, sponsors postgraduate medical education, and works on relevant legislative issues.
Pasi Jänne, MD, PhD, of Medical Oncology, received a Hope Now Award for Lung Cancer Research from Joans Legacy, a foundation that funds innovative research on lung cancer, particularly types that are unrelated to smoking.
Clark Chen, MD, PhD, and James Elliott Bradner, MD, have been named winners of prestigious Burroughs Wellcome Fund Career Awards. Chen was recognized for his proposal titled, "The molecular basis and therapeutic implications of genome instability during brain tumor progression." Bradner's proposal was titled, "Design and characterization of highly potent inhibitors of HDAC6."
Eric P. Winer, MD, director of Dana-Farber's Breast Oncology Center, has been appointed chief scientific advisor at Susan G. Komen for the Cure, the world's largest grassroots network of breast cancer survivors and activists.
Keith Ligon, MD, PhD, of Pediatric Oncology, has received the 2007 Peter A. Steck Young Investigator Award from the Pediatric Brain Tumor Foundation for a research paper on the role played by the Olig-2 gene pathway in brain tumor stem cells.
Greg Verdine, PhD, the Erving Professor of Chemistry at Harvard University and director of the Chemical Biology Initiative at Dana-Farber, and his former graduate student Anirban Banerjee, PhD, have received the 2007 Nobel Laureate Signature Award for Graduate Education in Chemistry from the American Chemical Society.
Peter Black, MD, chief of Neurosurgical Oncology at Dana-Farber and chairman of the Department of Neurosurgery at both Brigham and Women's and Children's Hospital Boston, was awarded the Charles Wilson Lifetime Achievement Award in Neuro-oncology. Presented in Washington, D.C., on April 14, the honor is given by the AANS Section on Brain Tumors to recognize an individual who has made significant contributions to the field of brain tumor research and therapy.
Robert Soiffer, MD, chief of the Division of Hematologic Malignancies, has been installed as president of the American Society for Blood and Marrow Transplantation (ASBMT). Marked with a ceremonial passing of the gavel at the president's dinner during this year's ASBMT annual conference in Keystone, Colo., Soiffer's year-long term officially began Feb. 12, 2007.
William G. Kaelin, MD, of Medical Oncology was one of seven recipients of a 2006 Doris Duke Distinguished Clinical Scientist Award (DCSA) for his work on tumor suppressor proteins.
Robert Sachs, a Dana-Farber trustee and 21-year cancer survivor, was elected board chairman of the National Coalition for Cancer Survivorship in February 2007.
Rosalind Segal, MD, PhD, of Pediatric Oncology, has been awarded a 2006 NIH Director's Pioneer Award, a prestigious five-year, $2.5 million grant to support her research of the way complex sugars work to maintain neural stem cells in the developing and adult brain. Segal was one of only 13 researchers to receive the grant. The Pioneer Award, established three years ago, is a key component of the National Institutes of Health (NIH) Roadmap for Medical Research. The program supports exceptionally creative scientists who take highly innovative approaches to major challenges in biomedical research.
Joseph Sodroski, MD, of Cancer Immunology and AIDS, has been awarded the second annual Retrovirology Prize. The prize is awarded annually and recognizes an outstanding mid-career retrovirologist.
Scott Armstrong, MD, PhD, of Pediatric Oncology, has received the 2006 Wilson S. Stone Memorial Award recognizing young researchers who have made outstanding contributions to biomedical sciences in the United States. The presentation of the award will be made at the annual Symposium on Fundamental Cancer Research sponsored by the University of Texas M.D. Anderson Cancer Center.
Stuart F. Schlossman, MD, Baruj Benacerraf Professor of Medicine and former chief of the Division of Tumor Immunology at Dana-Farber, was awarded an honorary doctorate from the Ruprecht Karls University in Heidelberg, Germany, in 2006.
George P. Canellos, MD, senior physician and former chief of Medical Oncology, received the 2006 Frank S. Moran Clinical Leadership Award from the University of Michigan Cancer Center at Ann Arbor. He delivered the keynote lecture at the university-sponsored symposium on March 25, 2006, focusing on hematologic malignancies.
Jay Harris, MD, chair of the Department of Radiation Oncology, was honored with a Pathfinder Award at the American Society of Breast Disease's 30th anniversary symposium on April 27, 2006. Harris was one of seven internationally distinguished breast cancer leaders to receive this recognition.
David G. Nathan, MD, president emeritus of Dana-Farber, was awarded the 2006 Walker Prize from Boston's Museum of Science for "meritorious published scientific investigation and discovery." President of Dana-Farber from 1995 to 2000, Dr. Nathan is recognized as one of the world's leading hematologists.
Holcombe Grier, MD, of Pediatric Oncology, has been named vice president of the American Society of Pediatric Hematology-Oncology (ASPHO). Grier will hold this position for the next two years, after which he will become president of this professional society, which represents pediatric hematologists and oncologists throughout the U.S.
The ASCI Award, given by the American Society of Clinical Investigation, has been renamed the Stanley J. Korsmeyer Award in honor of Dr. Korsmeyer, who passed away in March 2005. The annual award recognizes the outstanding achievements of a member in advancing knowledge in a specific field and in mentoring future generations of life-science researchers. Dr. Korsmeyer was the award's first recipient in 1998.
Susan Block, MD, chief of the Division of Psychosocial Oncology and Palliative Care at Dana-Farber and Brigham and Women's Hospital (BWH), has been recognized by the American Academy of Hospice and Palliative Medicine (AAHPM) for her work educating the next generation of leaders in this field, which focuses on care for those facing life-threatening or terminal illnesses. She was honored with her husband, J. Andrew Billings, MD, with whom she co-directs the Harvard Medical School Center for Palliative Care.
Robert J. Mayer, MD, of Medical Oncology, has been named chair of the Lustgarten Foundation for Pancreatic Cancer Research scientific advisory board. Mayer, director of the Center for Gastrointestinal Oncology at Dana-Farber, will oversee medical and investigative efforts for the Bethpage, N.Y.-based institution.
David S. Pellman, MD, of Pediatric Oncology has been chosen as one of the two 2006 E. Mead Johnson Award winners. This prestigious award has been given by the Society for Pediatric Research since 1939, and honors outstanding scientific research achievements in pediatrics.
Edward J. Benz, Jr., MD, president of Dana-Farber, has been elected vice-president and president-elect of the Association of American Cancer Institutes (AACI). Dr. Benz begins a two-year term at the 2005 AACI Annual Meeting in October, followed by a two-year term as president.
George Canellos, MD, received the San Salvatore Foundation Award in recognition of his contributions to the field of lymphoma research. He was honored at the 9th International Conference on Malignant Lymphoma in Lugano, Switzerland, held in June 2005.
David G. Nathan, MD, president emeritus of Dana-Farber, will receive the most distinguished award in academic internal medicine, the George M. Kober Medal, from the Association of American Physicians in April 2006. He will be only the third physician ever honored with both the Kober Medal and the John Howland Award of the American Pediatric Society, which he garnered in 2003.
Loren Walensky, MD, PhD, a postdoctoral research fellow and attending physician in pediatric oncology at Dana-Farber and Children's Hospital Boston, has won the prestigious and highly competitive 2005 Burroughs Wellcome Fund Career Award in the Biomedical Sciences. The $500,000 award was one of only 22 given nationwide this year to outstanding young researchers as a financial bridge to their first faculty positions.
Akila Viswanathan, MD, of Radiation Oncology is this year's recipient of theChampion Exposition ServicesInvestigator Award for her research into women's cancers. The award comes with a $100,000 gift, which will be used by Viswanathan to research lifestyle risk factors of endometrial cancer.
Jennifer R. Brown, MD, PhD, and Ann LaCasce, MD, of Medical Oncology have each received Clinical Investigator Career Development Awards from the Lymphoma Research Foundation.
Ruth Ruprecht, MD, PhD, of Cancer Immunology and AIDS, was one of just three people honored in November 2004 by the American Foundation for AIDS Research (amfAR) for her "outstanding contributions to the field of women and HIV/AIDS." Specifically, Ruprecht was recognized for her work in developing drug therapies to reduce mother-to-child transmission of HIV.
Pamela Silver, PhD, of Cancer Biology, has been named director of Harvard University's new doctoral program in systems biology. The program is expected to enroll its first class in the fall of 2005.
James B. Conway, Dana-Farber's chief operating officer and executive vice president, has been named to the Institute of Medicine's Committee on Drug Safety, a national panel investigating the causes of medication errors and the impact of efforts to reduce them. His appointment began in the fall of 2005 and will continue into 2006.
Ronald DePinho, MD, has been accorded one of the highest honors in the fields of medicine and health, election to the prestigious Institute of Medicine (IOM). The IOM, which is part of the National Academies of Science, has 1,416 active members and is a national resource and advisory body for independent, scientifically informed analysis and recommendations on human health issues.
Susan M. Bauer-Wu, DNSc, RN, has been selected to present the 24th Annual Mara Mogensen Flaherty Memorial Lectureship at the 2005 Oncology Nursing Society (ONS) Congress in Orlando, FL. Wu was selected for her "many contributions to the field of psychosocial oncology."
Trudi Feinstein, a Dana-Farber volunteer, has received a Local Hero Award from the Susan G. Komen Breast Cancer Foundation for her exceptional commitment to increasing breast cancer awareness.
George Daley, MD, PhD, has been awarded one of the nine inaugural Pioneer Awards given by the director of the National Institutes of Health (NIH). The award provides up to $500,000 each year for five years to "investigators of exceptionally creative abilities and diligence ... to allow them to develop and test far-ranging ideas."
Nika Danial, PhD, a postdoctoral fellow in the Cancer Immunology and AIDS laboratory of Stanley Korsmeyer, MD, has received the 2004 Burroughs Wellcome Fund Career Award in the Biomedical Sciences.
Patricia Reid Ponte, RN, DNSc, Dana-Farber's senior vice president of Patient Care Services and chief of Nursing, has been named a fellow of the American Academy of Nursing (AAN) and will be inducted Nov. 13 in Washington, D.C.
Patricia Reid Ponte, RN, DNSc, Dana-Farber's senior vice president of Patient Care Services and chief of Nursing, received the Mary B. Conceison Award for Excellence in Nursing Leadership in June 2004. The award, presented by the Massachusetts Organization of Nursing Executives, is regarded as the state's most prestigious nursing leadership award.
Bruce Spiegelman, PhD, of Cancer Biology has received a second consecutive MERIT award from the National Institutes of Health for his studies on cell development. Providing 10 years of research funding, the much-desired distinction - whose name stands for Method to Extend Research In Time - is bestowed on scientists whose accomplishments are a strong indicator of continued success.
Edward J. Benz, Jr., MD, president of Dana-Farber, has been elected to the American Academy of Arts and Sciences, the nation's oldest scholarly society. Benz and the other newly elected world-renowned leaders in scholarship, business, the arts, and public affairs will be formally inducted into the society this October, 2004.
Emil Frei III, MD, physician-in-chief emeritus at Dana-Farber, has received the inaugural American Association for Cancer Research Award for Lifetime Achievement in Cancer Research. The award recognizes Frei's role in devising combination chemotherapy, which led to the first complete cure for childhood leukemia.
Lynda Chin, MD,Glenn Dranoff, MD, and William Sellers, MD, all of Medical Oncology, were elected to the American Society for Clinical Investigation (ASCI). The society recognizes physician-scientists for their scholarly achievements in biomedical research.
Barrett Rollins, MD, and James DeCaprio, MD, both of Medical Oncology, were inducted into the Association of America Physicians. The association recognizes individuals who are leaders in their fields.
Kwok-Kin Wong, MD, PhD, of Medical Oncology, was recently named a Kimmel Scholar by the Sidney Kimmel Foundation for Cancer Research for his work on molecular mechanisms responsible for abnormal cell aging related to cancer.
Frederick Li, MD, of Medical Oncology, was awarded the Jack E. White/LaSalle D. Leffall Jr. Award for Cancer Prevention and Control on March 27, 2004. Li received this national honor for his work to address the unequal burden of cancer borne by members of minority groups in this country.
Todd Golub, MD, the Charles A. Dana Investigator at Dana-Farber, has won an award from the Freedom to Discover Program of Bristol-Myers Squibb that recognizes leading scientists and research institutes that are pioneers in combating disease.
Ruth Ruprecht, MD, PhD , of Cancer Immunology and AIDS, has been appointed to serve a four-year term on the official advisory council of the National Institute of Allergy and Infectious Diseases (NIAID).
Harley Haynes, MD, a skin cancer expert at Dana-Farber, received the Dermatology Foundation's Lifetime Career Educator Award on Feb. 7, 2004. The distinction honors a full-time academic who has dedicated his or her career to educating dermatology residents and fellows.
Stanley J. Korsmeyer, MD, the Sidney Farber Professor of Pathology at Dana-Farber and a professor of medicine at Harvard Medical School, is the recipient of the seventh annual Pezcoller Foundation-American Association for Cancer Research International Award for Cancer Research for his pioneering studies in programmed cell death, or apoptosis. Korsmeyer will be formally recognized by the foundation in the spring of 2004.
Emil Frei III, MD, physician-in-chief emeritus at Dana-Farber, has been awarded the second annual Pollin Prize in Pediatric Research for his contributions to the advances in the treatment of children with acute lymphoblastic leukemia. The prize is funded by the Linda and Kenneth Pollin Foundation and administered by New York-Presbyterian Hospital.
Edward J. Benz Jr., MD, president of Dana-Farber, has been elected a fellow of the American Association for the Advancement of Science (AAAS). He was recognized by the Association for his fundamental studies unraveling the genetic mechanisms of blood cell differentiation and diversity.
Anna Marie Kenney, PhD, of Pediatric Oncology, has received the Distinguished Scientist Award from the Sontag Foundation, an honor that will support her research into childhood brain tumors.
Pamela Silver, PhD, of Cancer Biology, has received a prestigious MERIT Award from the National Institutes of Health, which will provide her with uninterrupted funding for the next 10 years. Silver's work involves how proteins and RNA molecules move in and out of the cell's nucleus, a key part of regulating cell activities.
James D. Griffin, MD, chair of Medical Oncology, and William Kaelin, MD, of Medical Oncology, have been elected to the Johns Hopkins University Society of Scholars. Griffin and Kaelin were honored during the society's 34th induction ceremony on May 21, and again at the university's Commencement Ceremony on May 22. The society inducts former postdoctoral fellows and junior or visiting faculty at Johns Hopkins who have gained marked distinction in their fields of physical, biological, medical, social, or engineering sciences or in the humanities.
Stephen E. Sallan, MD, chief of staff at Dana-Farber, was named the first Boston Red Sox Biomedical All-Star in recognition of his work on behalf of children diagnosed with leukemia. The award was announced during a pre-game ceremony at Fenway Park on April 18, in which Dr. Sallan threw out the game's first pitch.
Ronald A. DePinho, MD, of Medical Oncology, has been named by the American Association of Cancer Research (AACR) as the recipient of its 43rd AACR-G.H.A. Clowes Memorial Award, the organization's oldest honor. The award recognizes recent outstanding achievement in basic cancer research.
Susan Block, MD, chief of the Division of Psychosocial Oncology and Palliative Care, is this year's recipient of the Distinguished Service Award from the American Academy of Hospice and Palliative Medicine (AAHPM).
Bruce Spiegelman, PhD, of Cancer Biology, traveled to Stockholm, Sweden, in February to receive the 3rd annual Rolf Luft Award for his groundbreaking research in endocrinology.
David G. Nathan, MD, president emeritus of Dana-Farber, has been named by the American Pediatric Society (APS) as its 2003 recipient of the John Howland Medal, its highest tribute. The award is presented to individuals whose service to pediatrics has helped advance the field.
Alan D'Andrea, MD, of Pediatric Oncology, received the Fanconi Anemia Research Fund's Award of Merit at the fund's annual symposium on Dec. 3, 2002. He is only the third recipient of this tribute, the organization's highest, and was recognized for his research on Fanconi anemia, an inherited condition that results in bone marrow failure in children and a variety of cancers later in life.
David G. Nathan, MD, president emeritus of Dana-Farber, was awarded the title of doctor honoris causa from the University of Athens in a Nov. 20 ceremony. The title is the highest honorary award given by the university.
Stanley J. Korsmeyer, MD, the Sidney Farber Professor of Pathology at Dana-Farber and a professor of medicine at Harvard Medical School, was named the winner of the Association of American Medical Colleges' 2002 Award for Distinguished Research in the Biomedical Sciences. The honor was presented during a ceremony on Nov. 9 at the AAMC's 113th Annual meeting in San Francisco.
James DeCaprio, MD, of Medical Oncology, has been named a 2002 Stohlman Scholar by the Leukemia & Lymphoma Society (LLS). DeCaprio studies mechanisms by which cells become cancerous.
Susan DeCristofaro, RN, MS, OCN, director of Patient/Family Education at Dana-Farber, was recently elected chair of the National Cancer Institute's Cancer Patient Education Network.
Pamela Silver, PhD, of Cancer Biology, received this year's Harvard Medical School Biological and Biomedical Sciences Mentoring Award.
Lee Nadler, MD, senior vice president for Experimental Medicine, has been appointed the first incumbent of the Virginia and D.K. Ludwig Chair for Cancer Research at the Harvard Medical School. The Ludwig Foundation created this Chair with the express purpose of promoting the translation of basic science into clinically effective strategies and agents at Harvard.
Leonard Zon, MD, a faculty member in Pediatric Oncology and Adult Oncology at DFCI and a Howard Hughes Medical Investigator at Children's Hospital Boston, has been elected president of the American Society for Clinical Investigation. His term will begin in May 2004.
Richard Gelber, PhD, of Biostatistical Science received the 2002 European Institute of Oncology Breast Cancer Award on June 5 during the Fourth Annual Milan Breast Cancer Conference in Milan, Italy. He was recognized for his contributions as a biostatician for cancer clinical trials.
Todd Golub, MD, was selected in May as one of 12 of the nation's top physician-scientists to be appointed as HHMI investigators by the Howard Hughes Medical Institute.
Lee Nadler, MD, senior vice president of Experimental Medicine, received the 2002 Joseph H. Burchenal Clinical Cancer Research Award from the American Association for Cancer Research. The award recognizes outstanding achievements in clinical cancer research.
Todd Golub, MD, of Pediatric Oncology, received the 2002 Cornelius P. Rhoads Memorial Award from the American Association for Cancer Research. The award recognizes a young investigator who has conducted highly meritorious cancer research.
Joseph Antin, MD, chief of the Adult Oncology Bone Marrow Transplant Team, has been named as the president-elect of the American Society for Blood and Marrow Transplantation.
William Hahn, MD, PhD, of Adult Oncology has been selected for a Kimmel Translational Scholar Award for his studies into the ways in which genetic changes in cells transform them into cancers.
Harvey Cantor, MD, and Bruce Spiegelman, PhD, have been elected to the National Academy of Sciences. Considered one of the highest honors that can be accorded a U.S. scientist or engineer, election to membership in the Academy recognizes a scientist for distinguished and continuing achievements in original research. They become the eighth and ninth Dana-Farber researchers to hold membership in the Academy.
Emil Frei III, MD, physician-in-chief emeritus, was recognized in February for his long and distinguished career by colleagues at the International Congress on Anti-Cancer Treatment, who presented him in Paris with the Claude Jacquillat Award for achievement in clinical oncology.
Stanley J. Korsmeyer, MD, was named co-winner of the first Wiley Prize in the Biomedical Sciences in February 2002.
George Demetri, MD, co-director, Center for Sarcoma and Bone Oncology; Judy Garber, MD, director, Cancer Risk and Prevention Program; Robert Mayer, MD, vice chair for Academic Affairs and director, Center for Gastrointestinal Oncology; Ursula Matulonis, MD, Adult Oncology; and Lawrence Shulman, MD, vice chair for Clinical Services, were named to Boston Magazine's top doctors list in its February 2002 issue.
Samuel Lux, MD, of Pediatric Oncology, was the recipient in December 2001 of an E. Donnall Thomas Award from the American Society of Hematology.
Jay Harris, MD, Chair of Radiation Oncology, received the prestigious Brinker International Award of the Susan Komen Breast Cancer Foundation for outstanding accomplishments.
James B. Conway, senior vice president and chief operations officer at Dana-Farber Cancer Institute, was named the winner of the first Individual Leadership Award in Patient Safety by the Joint Commission on Accreditation of Healthcare Organizations (JCAHO) and the National Committee for Quality Assurance (NCQA).
William Kaelin, MD, of Adult Oncology, was recently awarded the Paul Marks Prizes for Cancer Research. The awards were established this year by Memorial Sloan-Kettering in New York to recognize scientists under age 45 who have made significant contributions to the understanding of the basic biology of cancer or to the clinical care of cancer patients.
Hal Burstein, MD, in Dana-Farber's Women's Cancers Program was awarded the George P. Canellos Award for Excellence in Clinical Investigation and Patient Care.
Stanley Korsmeyer, MD, of Cancer Immunology and AIDS and chair of the Executive Committee for Research at DFCI, received the 2001 Robert Roesler de Villiers International Achievement Award for his work pursuing a genetic approach to the regulation of programmed cell death.
Dana Gabuzda, MD, of Cancer Immunology and AIDS, received an American Foundation for AIDS Research (AmFAR) award for her work identifying molecules that might play a role in preventing HIV from infecting healthy cells and spreading through the body.
James Griffin, MD, of Adult Oncology, received the 15th annual Dr. Anthony Cortese Award for his work on, among other things, trying to understand how tyosine kinase oncogenes cause certain types of chronic leukemia.
Robert Soiffer, MD, DFCI's clinical director of Hematologic Oncology, was honored with the first Brian P. O'Dell Memorial Research Award for his efforts to develop strategies to modulate the immune system in the treatment of patients with cancer.
Sandy Chang, MD, PhD, of Adult Oncology, has been selected as one of 10 Ellison Medical Foundation New Scholars in Aging for 2001.
William Sellers, MD, of Adult Oncology, and David Livingston, MD, of Cancer Biology, received the prestigious Cancer Research Fund-Lilly Clinical Investigator Awards from the Damon Runyon-Walter Winchell Foundation for their ongoing research into the molecular classification of prostate cancer.
Dietmar Schmucker, PhD, Assistant Professor of Cancer Biology, recently won the Harcourt New Investigator Award. His research centers on neuron receptors.
Marian Heard and Tom May, trustees at Dana-Farber, were honored as New Englanders of the Year by the New England Council.
Koichi Akashi, MD, PhD, Assistant Professor of Cancer Immunology, was awarded both the Damon Runyon-Walter Winchell Cancer Research Scholar Award and the Medical Foundation New Investigator Award for his work on the analysis of leukemia development from hematopoietic progenitors.
Pasi Jänne, MD, PhD, and Ann Partridge, MD, of Adult Oncology, received Young Investigator Awards from the American Society of Clinical Oncology (ASCO) at its annual meeting in May 2001.
